Evaluation of suspected malignant hyperthermia events during anesthesia
Conclusions:
MH is still an important anesthetic complication. Every anesthetist must be aware of this life-threatening syndrome at any time. The rapid onset of adequate therapy is crucial to avoid major harm and possibly lethal outcome. Dantrolene must be readily available wherever MH triggering agents are used for anesthesia.
Source: BMC Anesthesiology - Category: Anesthesiology Authors: Frank SchusterStephan JohannsenDaniel SchneiderbangerNorbert Roewer Source Type: research
More News: Anesthesia | Anesthesiology | Arrhythmia | Cancer & Oncology | Cardiac Arrhythmia | Medical Ethics | Study